19-48970770-A-T
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002103.5(GYS1):c.1646-61T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.382 in 1,534,400 control chromosomes in the GnomAD database, including 112,697 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_002103.5 intron
Scores
Clinical Significance
Conservation
Publications
- glycogen storage disease due to muscle and heart glycogen synthase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen, Genomics England PanelApp, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GYS1 | NM_002103.5 | c.1646-61T>A | intron_variant | Intron 13 of 15 | ENST00000323798.8 | NP_002094.2 | ||
GYS1 | NM_001161587.2 | c.1454-61T>A | intron_variant | Intron 12 of 14 | NP_001155059.1 | |||
GYS1 | NR_027763.2 | n.1661-61T>A | intron_variant | Intron 12 of 14 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.395 AC: 59799AN: 151462Hom.: 11926 Cov.: 30 show subpopulations
GnomAD4 exome AF: 0.380 AC: 525635AN: 1382820Hom.: 100753 Cov.: 22 AF XY: 0.380 AC XY: 262614AN XY: 691684 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.395 AC: 59862AN: 151580Hom.: 11944 Cov.: 30 AF XY: 0.390 AC XY: 28904AN XY: 74056 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:2
- -
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at